Additive channels

US11150255B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11150255-B2
Application numberUS-201715648182-A
CountryUS
Kind codeB2
Filing dateJul 12, 2017
Priority dateJul 12, 2016
Publication dateOct 19, 2021
Grant dateOct 19, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions, devices and methods are described for preventing, reducing, controlling or delaying adhesion, adsorption, surface-mediated clot formation, or coagulation in a microfluidic device or chip. In one embodiment, blood (or other fluid with blood components) that contains anticoagulant is introduced into a microfluidic device comprising one or more additive channels containing one or more reagents that will re-activate the native coagulation cascade in the blood that makes contact with it “on-chip” before moving into the experimental region of the chip.

First claim

Opening claim text (preview).

The invention claimed is: 1. A system comprising: a) a microfluidic device comprising: an input channel; an output channel; a test channel disposed in a solid substrate, wherein said test channel comprises an input portion in fluidic communication with said input channel and an output portion in fluidic communication with said output channel; endothelial cells disposed within at least one portion of said test channel; and an output additive channel, wherein said output additive channel is in fluidic communication with said output portion of said test channel; b) an input channel reservoir in fluidic communication with said input channel; c) an output additive channel reservoir in fluidic communication with said output additive channel, said output additive channel reservoir comprising one or more reagents that inactivate a native coagulation cascade of blood; and d) a pressure source adapted to apply pressure to both said input channel reservoir and said output additive channel reservoir. 2. The system of claim 1 , wherein said output additive channel is configured to provide a fluidic resistance that is proportional to the fluidic resistance of said input channel. 3. The system of claim 1 , wherein said output additive channel comprises a first fluidic resistor, and input channel comprises a second fluidic resistor. 4. The system of claim 1 , wherein said endothelial cells are living cells. 5. The system of claim 4 , wherein said living cells form a lumen. 6. A system comprising: a) a microfluidic device comprising: an input channel; an output channel; a test channel, wherein said test channel comprises an input portion in fluidic communication with said input channel and an output portion in fluidic communication with said output channel; endothelial cells disposed within at least one portion of said test channel; and an output additive channel, wherein said output additive channel is in fluidic communication with said output portion of said test channel; b) an input channel reservoir in fluidic communication with said input channel; c) an output additive channel reservoir in fluidic communication with said output additive channel, said output additive channel reservoir and comprising one or more reagents that inactivate a native coagulation cascade of blood and is integrated on the microfluidic device; and d) a pressure source adapted to apply pressure to both said input channel reservoir and said output additive channel reservoir. 7. The system of claim 6 , wherein said output additive channel is configured to provide a fluidic resistance that is proportional to the fluidic resistance of said input channel. 8. The system of claim 6 , wherein said output additive channel comprises a first fluidic resistor, and input channel comprises a second fluidic resistor. 9. The system of claim 6 , wherein said endothelial cells are living cells and said living endothelial cells form a lumen. 10. A system comprising: a) a microfluidic device comprising: an input channel; an output channel; a test channel, wherein said test channel comprises an input portion in fluidic communication with said input channel and an output portion in fluidic communication with said output channel; endothelial cells disposed within at least one portion of said test channel; and an output additive channel, wherein said output additive channel is in fluidic communication with said output portion of said test channel; b) an input channel reservoir in fluidic communication with said input channel; c) an output additive channel reservoir in fluidic communication with said output additive channel, said output additive channel reservoir comprising one or more reagents that inactivate a native coagulation cascade of blood; and d) a pressure source adapted to apply pressure to both said input channel reservoir and said output additive channel reservoir. 11. The system of claim 10 , wherein said output additive channel is configured to provide a fluidic resistance that is proportional to the fluidic resistance of said input channel. 12. The system of claim 10 , wherein said output additive channel comprises a first fluidic resistor, and input channel comprises a second fluidic resistor. 13. The system of claim 10 , wherein said endothelial cells are living cells. 14. The system of claim 13 , wherein said living cells form a lumen. 15. The system of claim 1 , said pressure source is fluidically connected in parallel with both said input channel reservoir and said output additive channel reservoir. 16. The system of claim 6 , said pressure source is fluidically connected in parallel with both said input channel reservoir and said output additive channel reservoir. 17. The system of claim 10 , said pressure source is fluidically connected in parallel with both said input channel reservoir and said output additive channel reservoir.

Assignees

Inventors

Classifications

  • Multiple inlets and one sample wells, e.g. mixing, dilution · CPC title

  • Handling flowable solids, e.g. microscopic beads, cells, particles · CPC title

  • Laminated structure · CPC title

  • rectangular shaped · CPC title

  • Cards, e.g. flat sample carriers usually with flow in two horizontal directions · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11150255B2 cover?
Compositions, devices and methods are described for preventing, reducing, controlling or delaying adhesion, adsorption, surface-mediated clot formation, or coagulation in a microfluidic device or chip. In one embodiment, blood (or other fluid with blood components) that contains anticoagulant is introduced into a microfluidic device comprising one or more additive channels containing one or mor…
Who is the assignee on this patent?
Emulate Inc
What technology area does this patent fall under?
Primary CPC classification B01L3/502746. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).